Home / Market News / $BAK

$BAK news and market catalysts

The 6 most recent market catalysts affecting $BAK, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

6 catalysts 2 high impact 1 bullish 4 bearish Chemicals
Nov 7, 2026 Corporate Catalyst Bearish Impact 85
Petrobras Withdraws $1.4 Billion Funding Offer for Braskem
Petrobras and IG4's decision to withdraw their $1.4 billion funding offer for Braskem is a direct consequence of creditors in New York rejecting a larger $3.8 billion debt conversi…
Oct 26, 2026 Corporate Catalyst Bullish Impact 85
Braskem Nears Debt Restructuring Agreement
Braskem S.A. is reportedly close to a major debt restructuring agreement involving $11 billion. This event is a significant corporate catalyst as it addresses a substantial financi…
Sep 28, 2026 Corporate Catalyst Bearish Impact 65
HSBC Downgrades Braskem to Hold, Lowers Price Target to $1.5
HSBC analyst Sriharsha Pappu downgraded Braskem (BAK) from a 'Buy' to a 'Hold' rating and drastically cut the price target from $6.5 to $1.5. This significant revision by a promine…
Sep 18, 2026 Corporate Catalyst Neutral Impact 75
Transcript: Braskem Q2 2026 Earnings Conference Call
Braskem's Q2 2026 earnings call transcript reveals a substantial 261% increase in recurring EBITDA for its Brazil segment, reaching $1.043 billion. This impressive performance is a…
Sep 16, 2026 Corporate Catalyst Bearish Impact 75
Braskem shares are trading lower after UBS downgraded the stock from Neutral to Sell and lowered its price target from $4 to $1.5.
This downgrade by a major investment bank like UBS is a significant corporate catalyst for Braskem. The substantial reduction in the price target from $4 to $1.5 indicates a strong…
Sep 16, 2026 Corporate Catalyst Bearish Impact 65
UBS Downgrades Braskem to Sell, Lowers Price Target to $1.5
UBS analyst Tasso Vasconcellos has downgraded Braskem (BAK) from Neutral to Sell and slashed its price target from $4 to $1.5. This is a significant negative development for Braske…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.